03.26.2018

ESMA Updates MIFID/MIFIR Q&As

03.26.2018

The European Securities and Markets Authority (ESMA) has included 7 new or updated items in its Questions and Answers (Q&A) document on the implementation of investor protection topics under the Market in Financial Instruments Directive and Regulation (MiFID II/ MiFIR).

The updated Q&As are on the topics of inducements (research) and information on costs and charges. The other four Q&As are new and relate to the topics of inducements, post-sale reporting and other issues

The overall MiFID II Q&A provide clarifications on the following topics:

  • Best execution
  • Suitability and appropriateness
  • Recording of telephone conversations and electronic communications
  • Post-sale reporting
  • Record keeping
  • Investment advice on an independent basis
  • Inducements (research)
  • Information on charges and costs
  • Underwriting and placement of a financial instrument
  • Client categorisation
  • Inducements
  • Provision of investment services and activities by third country firms
  • Application of MiFID II after 3 January 2018, including issues of ‘late transposition’
  • Other issues

MiFID II applies from 3 January 2018 and will strengthen the protection of investors by both introducing new requirements and reinforcing existing ones. The purpose of this Q&A is to promote common supervisory approaches and practices in the application of MiFID II/MiFIR for investor protection topics.

Related articles

  1. Daily Email Feature

    Nasdaq Clearing Expands in IRS

    The European Commission has proposed an active account requirement under EMIR 3.0.

  2. The European Commission said the United Arab Emirates has deficiencies in anti-money laundering.

  3. OCC Boosts Risk Management

    The build-up of exposures by the collapsed US family office can be seen in EMIR data.

  4. The trade repository has been providing UK services since the first business day after Brexit on 4 Jan 2021.

  5. The trade repository failed to ensure data integrity and provide access to regulators.